Oncolytic Vaccinia Virus Harboring Aphrocallistes vastus Lectin Inhibits the Growth of Hepatocellular Carcinoma Cells

Oncolytic vaccinia virus has been developed as a novel cancer therapeutic drug in recent years. Our previous studies demonstrated that the antitumor effect of oncolytic vaccina virus harboring Aphrocallistes vastus lectin (oncoVV-AVL) was significantly enhanced in several cancer cells. In the presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Riqing, Qiu, Yufeng, Zhang, Xiaomei, Zhou, Ningning, Jia, Xiaoyuan, Chen, Kan, Zhou, Yanrong, Ye, Ting, Li, Gongchu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230886/
https://www.ncbi.nlm.nih.gov/pubmed/35736181
http://dx.doi.org/10.3390/md20060378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230886/
https://www.ncbi.nlm.nih.gov/pubmed/35736181
http://dx.doi.org/10.3390/md20060378

Ejemplares similares